Discounted Cash Flow Rating

Strong Buy

Return on Equity Rating

Strong Sell

Debt to Equity Rating

Buy

Price to Earnings Rating

Strong Sell

Analyst Rating

Neutral

Simple Moving Average

Neutral

Exponential Moving Average

Neutral

Relative Strength Index

Strong Buy

Standard Deviation

Strong Sell

Williams %R

Strong Buy

Average Directional Index

Strong Sell

Insider Trading

Strong Buy

Wall Street Data Solutions Rating

Neutral

B

IO Biotech, Inc. Common Stock (IOBT)

Pharmaceutical Preparations

https://www.iobiotech.com

IO Biotech Inc is a clinical-stage biopharmaceutical company developing novel, immune-modulating cancer vaccines based on T-win technology platform. The product candidates are designed to induce the immune system to simultaneously target and disrupt multiple pathways that regulate tumor-induced immunosuppression.

OLE MAALOES VEH 3
COPENHAGEN, G7

Current Price

---.--

% Change Today

0.00%

Change Amt. Today

0.00

Active Status

Active

Listing Date

11/05/2021

Market Cap

90,915,656

Shares Outstanding

65,879,999

Weighted SO

65,880,914

Total Employees

N/A

Upcoming Earnings

08/09/2024

Similar Tickers

PMVP --.--%

ELYM --.--%

MNOV --.--%

PHVS --.--%

PEPG --.--%

PRDS --.--%

STTK --.--%

CSBR --.--%

IPSC --.--%

Beta

0.4810

Last Div

0.0000

Range

0.816-2.098

Chg

0.0300

Avg Vol

136904

Mkt Cap

90915656

Exch

NASDAQ

Country

DK

Phone

45 70 70 29 80

DCF Diff

-1.8515

DCF

3.2315

Div Yield

0.0000

P/S

81.9060

EV Multiple

0.0842

P/FV

0.9444

Div Yield %

0.0000

P/E

-1.0331

PEG

-0.0512

Payout

0.0000

Current Ratio

7.8446

Quick Ratio

7.8446

Cash Ratio

7.3415

DSO

338.6937

DIO

0.0000

Op Cycle

338.6937

DPO

2232.7317

CCC

-1894.0380

Gross Margin

0.2613

Op Margin

-84.1414

Pretax Margin

-78.6495

Net Margin

-79.2829

Eff Tax Rate

-0.0081

ROA

-0.7895

ROE

-0.7005

ROCE

-0.9555

NI/EBT

1.0081

EBT/EBIT

0.9347

EBIT/Rev

-84.1414

Debt Ratio

0.0193

D/E

0.0223

LT Debt/Cap

0.0151

Total Debt/Cap

0.0218

Int Coverage

-72.6260

CF/Debt

-37.5344

Equity Multi

1.1578

Rec Turnover

1.0777

Pay Turnover

0.1635

Inv Turnover

0.0000

FA Turnover

0.4156

Asset Turnover

0.0100

OCF/Share

-1.2249

FCF/Share

-1.2273

Cash/Share

1.5292

OCF/Sales

-72.7018

FCF/OCF

1.0020

CF Coverage

-37.5344

ST Coverage

-119.0251

CapEx Coverage

-507.5409

Div&CapEx Cov

-507.5409

P/BV

0.9444

P/B

0.9444

P/S

81.9060

P/E

-1.0331

P/FCF

-1.1244

P/OCF

-1.1266

P/CF

-1.1266

PEG

-0.0512

P/S

81.9060

EV Multiple

0.0842

P/FV

0.9444

DPS

0.0000

Latest Headlines (EST)

GlobeNewswire Inc. Apr 26, 19:05 IO Biotech Showcases Scientific Leadership Through Cancer Vaccines Educational Session at the American Association for Cancer Research (AACR) Annual Meeting 2025 GlobeNewswire Inc. Dec 21, 08:30 IO Biotech Announces First Patient Dosed in Phase 2 Neoadjuvant/Adjuvant Solid Tumor Basket Trial Benzinga Nov 27, 13:41 Why Anavex Life Sciences Shares Are Trading Lower By Around 10%? Here Are Other Stocks Moving In Monday's Mid-Day Session GlobeNewswire Inc. Nov 08, 16:30 IO Biotech Announces Participation in Upcoming Investor Conferences

Revenue Product Segmentation